Osteoporosis Drug Approved for Cancer-Related Bone Pain
November 23, 2010 | Filed under: Health,News | Posted by:
The FDA has approved Xgeva, an osteoporosis drug reformulated to reduce the risk of bone fractures and bone pain in patients with cancer that has spread throughout the body.
Posted by
on November 23, 2010. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
Posted by
on November 23, 2010. Filed under